Skip to main content
. 2021 Sep 14;13(18):4610. doi: 10.3390/cancers13184610
5-FU 5-Fluorouracil
ADCC Antibody-dependent cell cytotoxicity
BM Bone marrow
BME Basement membrane extract
CAF Cancer-associated fibroblasts
CAR Chimeric antigen receptor
CEA Carcinoembryonic antigen
CCL2 C-C motif chemokine ligand 2
CSF1R Colony stimulating factor 1 receptor
CTL Cytotoxic T lymphocytes
CXCL12 C-X-C motif chemokine ligand 12
CXCR4 C-X-C chemokine receptor type 4
DC Dendritic cells
EC Endothelial cells
ECM Extracellular matrix
EGFR Epidermal growth factor receptor
EMT Epithelial to mesenchymal transition
FAP Fibroblast-activation protein
FGF-2 Fibroblast growth factor-2
G-CSF Granulocyte colony stimulating factor
HER2 Human epidermal growth factor receptor 2
HGF Hepatocyte growth factor
HUVEC Human umbilical vein endothelial cells
ICAM-1 Intercellular adhesion molecule 1
IFN-γ Interferon- γ
IL-6 Interleukin-6
LOX Lysyl oxidase
LPS Lipopolysaccharide
MDSC Myeloid-derived suppressor cells
MHC Major histocompatibility complex
MMP Matrix metalloproteinases
MSC Mesenchymal stromal cells
M-CSF Macrophage-colony stimulating factor
NK Natural Killer cells
PBMC Peripheral blood mononuclear cells
PEG Poly(ethylene) glycol
PD-1 Programmed cell death protein 1
PD-L1 Programmed death ligand 1
PDGF Platelet-derived growth factor
PMA Phorbol-12-myristate-13-acetate
ROS Reactive oxygen species
SMC Smooth muscle cells
TAM Tumour-associated macrophages
TGF-β Transforming growth factor β
TIMP-1 Tissue inhibitor of metalloproteinases 1
TME Tumour microenvironment
TNF-α Tumour necrosis factor α
Treg Regulatory T cells
VEGF Vascular endothelial growth factor
α-SMA α Smooth muscle actin